本页面由Tiger Trade Technology Pte. Ltd.提供服务

Rocket Pharmaceuticals, Inc.

3.27
+0.02000.62%
盘后3.380.1053+3.22%19:53 EST
成交量:153.62万
成交额:505.40万
市值:3.54亿
市盈率:-1.46
高:3.36
开:3.25
低:3.20
收:3.25
52周最高:11.11
52周最低:2.19
股本:1.08亿
流通股本:7,878.63万
量比:0.85
换手率:1.95%
股息:- -
股息率:- -
每股收益(TTM):-2.2397
每股收益(LYR):-2.7292
净资产收益率:-74.88%
总资产收益率:-40.56%
市净率:1.13
市盈率(LYR):-1.20

数据加载中...

公司资料

公司名字:
Rocket Pharmaceuticals, Inc.
交易所:
NASDAQ
成立时间:
1999
员工人数:
299
公司地址:
9 Cedarbrook Drive,Cranbury,New Jersey,United States
邮编:
08512
电话:
传真:
- -
简介:
Rocket Pharmaceuticals, Inc.于1999年7月7日根据特拉华州法律注册成立。该公司是一家完全整合的、处于后期阶段的生物技术公司,专注于开发首创、唯一和同类最佳的基因疗法,具有直接的靶向作用机制和明确的临床终点,用于罕见和破坏性疾病。

董事

名称
职位
Gaurav D. Shah
Director and Chief Executive Officer
Roderick Wong
Chairman of the Board
Carsten Boess
Independent Director
David P. Southwell
Independent Director
Elisabeth Bjork
Independent Director
Fady Ibraham Malik
Independent Director
Mikael Dolsten
Director
Peter Fong
Director
Piratip Pratuwan
Director

股东

名称
职位
Gaurav D. Shah
Director and Chief Executive Officer
Christopher Stevens
Chief Operating Officer
Martin Wilson
Interim Principal Financial Officer,Chief Corporate Officer, Senior Vice President and General Counsel
John Militello
Vice President, Finance, Treasurer and Principal Accounting Officer
Jonathan Schwartz
Chief Medical Officer and Chief Gene Therapy Officer
Sarbani Chaudhuri
Chief Commercial Officer and Chief Medical Affairs Officer